The business’s 50 day moving average price is $3.42 and its two-hundred day moving average price is $3.25. The company has a market capitalization of $782.27 million, a price-to-earnings ratio ...
Below is a chart showing AI's trailing twelve month trading history, with the $26 strike highlighted in orange: Organogenesis Holdings Inc (Symbol: ORGO) options are showing a volume of 6,174 ...
Hosted on MSN17d
Organogenesis (ORGO) Q4 2024 Earnings Call TranscriptRead More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. Operator Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings ...
2025 Adjusted EBITDA Guidance: $43.6 million to $83.2 million. Organogenesis Holdings Inc (NASDAQ:ORGO) reported a 27% increase in net revenue for the fourth quarter, exceeding the high end of ...
Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc. At this time, all participants have placed in ...
Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only ...
The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Organogenesis Holdings Inc for the upcoming quarter. Analysts have not changed this quarter's expectations for EPS ...
Organogenesis Holdings Inc (NASDAQ:ORGO) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $109.60 million, and the earnings are expected to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results